Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit Ruchika Sharma24 Dec 2022 12:30 PM ISTModerna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.
Drug price group slashes suggested price of Pfizer COVID drug Paxlovid by 80 percent Ruchika Sharma21 Dec 2022 10:00 AM ISTUS: An influential drug pricing research group has cut its suggested price range for Pfizer Inc's COVID-19 antiviral treatment Paxlovid by more than...
US Federal Court assures safety from Ranitidine, dismisses 2,500 lawsuits alleging cancer linkage with drug Ruchika Sharma19 Dec 2022 3:48 PM ISTThe court ruling comes as a big win for pharmaceutical companies like Pfizer, Sanofi, GSK and Boehringer Ingelheim.
Pfizer unveils Assistance app 'Pfizer PAP India' for Indian patients Ruchika Sharma18 Dec 2022 3:30 PM ISTPAP is executed by Tata 1 MG (MediAngels by TATA 1MG) on behalf of Pfizer India.
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030 Ruchika Sharma13 Dec 2022 12:13 PM ISTNew York: Pfizer Inc said on Monday that annual revenue from its mRNA vaccine portfolio could reach $10 billion to $15 billion by 2030, alleviating...
Pfizer secures USFDA priority review for RSV vaccine for older adults Ruchika Sharma8 Dec 2022 3:00 PM ISTRSV is a contagious virus and a common cause of respiratory illness.
Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits Ruchika Sharma7 Dec 2022 1:10 PM ISTA Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...
Pfizer, Clear Creek Bio collaborate for development of COVID oral treatment Ruchika Sharma7 Dec 2022 12:15 PM ISTClear Creek Bio will receive an undisclosed upfront payment and will be eligible to receive additional potential milestone payments plus royalties on...
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents Ruchika Sharma6 Dec 2022 1:30 PM ISTPfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in children under 5 years Ruchika Sharma6 Dec 2022 11:30 AM ISTNew York: Pfizer and BioNTech have announced that the companies have submitted an application to the U.S. Food and Drug Administration (USFDA) for...
Pfizer, Roivant form company to develop ulcerative colitis treatment Ruchika Sharma4 Dec 2022 3:45 PM ISTPfizer owns a 25% equity position in the Vant and maintains commercial rights outside of the US and Japan as well as representation on the company's...
Medical Bulletin 26/November/2022 Dr. Nandita Mohan26 Nov 2022 1:00 PM ISTHere are the top medical news for the day:Risk of severe asthma attacks doubled after Covid-19 restrictions liftedAdults with asthma had, at one...
